Autism spectrum disorder AIM To assess the prevalence and risk factors for autism spectrum disorder (ASD) in epilepsy, and to better understand the relationship and comorbidity between these disorders.
Epilepsy is an enduring predisposition for generating seizures which is active in approximately 0.4% to 0.8% of the population.
1,2 Autism spectrum disorder (ASD) is characterized by impairments in communication and social interactions along with the presence of repetitive and perseverant behaviours, and is prevalent in 0.75% to 1.1% of the population. [3] [4] [5] Notably, the presence of either disorder greatly augments the probability of developing the other. The coexistence between these disorders has been reported for over 50 years; however, many questions about their relation remain unanswered. 6 For instance, what is the prevalence of ASD in epilepsy? What factors increase the risk for cooccurrence? Is there a causal relationship between epilepsy and ASD, or do both disorders result from the same underlying risk factors?
The first question that arises concerns the exact prevalence and risk factors for the ASD-epilepsy comorbidity. For individuals with ASD, estimates of the prevalence of developing epilepsy in a lifetime range from 2.7% to 44.4%, [7] [8] [9] [10] [11] [12] [13] [14] [15] with a recent review reporting a sevenfold increased risk of epilepsy in individuals with ASD relative to the general population. 16 A key reported risk factor is the presence of intellectual disability, which increases epilepsy risk in ASD by three to five times. 7, 17 Other risk factors for epilepsy in ASD include female sex, 7 older age, 14 lower socio-economic status, 16 and a family history of ASD. 8 Another question relates to understanding the mechanisms underlying the high comorbidity between these disorders. One theory is that epilepsy may contribute to -or even cause -certain developmental impairments, thus predisposing an individual towards ASD. 18 Accordingly, early seizures have numerous disruptive effects on neural development, including lasting physiological and functional deficits in the hippocampus, abnormal synaptic reorganization, and cortical interneuron dysfunction. 19, 20 These seizures may cause maladaptive synaptic plasticity, leading to imbalances of the excitation/inhibition neurotransmitter systems which impairs learning and behavioural development. 18 This in turn disrupts the construction of cortical networks necessary for acquiring certain skills during development, and may predispose an individual towards developing ASD. 21 Alternatively, epilepsy and ASD may both be side effects of a common underlying neural pathology. [22] [23] [24] This is supported by findings that ASD and epilepsy have common biological pathways, such as abnormalities in gene transcription regulation, cellular growth, synaptic channel function, and/or dysregulation of the excitation/inhibition system. 22, 23 Further, risk of both epilepsy and ASD is elevated in numerous genetic disorders, such as Rett syndrome, fragile X syndrome, and tuberous sclerosis complex. 22 Current research postulates that these theories are not mutually exclusive and that they both contribute to the comorbidity seen between these disorders.
Where previous reviews have examined the risk of epilepsy in the individuals with ASD, 17 no review so far has examined the prevalence of ASD and risk factors in epilepsy. Thus, the main goal of this review is to identify and analyse prevalence and risk factors for ASD in different populations with epilepsy. In doing so, this review hopes to augment our understanding of the developmental outcomes and prognosis for individuals with epilepsy. Additionally, it aims to propose novel insights into the role of epilepsy in ASD and the complex relationship between these cooccurring disorders.
METHOD Search strategy and inclusion criteria
Articles were retrieved from PubMed and PsychINFO (November 2016) using the keywords 'epilepsy' and 'autism'. Articles were required to be presented in English, based on human research, and published within 15 years of the search date (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) . Each study also had to be conducted in a population with epilepsy where the entire population did not have an alternative medical condition (e.g. Down syndrome, cerebral palsy, tuberous sclerosis complex). Article abstracts needed to provide a prevalence statistic, odds ratio, or numerical report of the comorbidity of ASD in an epilepsy population. Full articles had to contain a reported or calculable prevalence statistic for ASD in the text (if not provided in the abstract).
Quality appraisal
Risk of bias in each study was assessed using a modified QUIPS tool, 25 adapted to suit the specific testing materials and methods used in the studies reviewed (Appendix S1, online supporting information). This appraisal method was chosen to examine the level of bias in each study and to determine the reliability of the individually reported prevalences. Of note, the quality appraisal was conducted specifically on the population with epilepsy in each study who partook in the ASD assessment and may not have referred to the entire population or other methodology in the paper.
Statistical analysis
As large heterogeneity between studies was anticipated owing to variations in baseline characteristics (e.g. epilepsy type, age, sex, presence of intellectual disability) in each sample, the pooled prevalence was calculated using a DerSimonian-Laird random effects model on the raw percentages. 26 Cochran's Q statistic was used to detect the presence of heterogeneity between studies. 27 The I 2 statistic was used to quantify the percentage of variation in the pooled prevalence that was due to heterogeneity between studies. 28 All analyses were conducted using metan 29 on Stata 14 (StataCorp, College Station, TX, USA).
RESULTS

Article selection
The initial search criteria yielded 1738 results. Of screened titles, 57 articles contained a prevalence or odds ratio for comorbid epilepsy and ASD, with 36 based in a population with ASD and 21 based in a population with epilepsy. Only one study was excluded from final analysis as it did not contain a calculable ASD prevalence in the text ( Fig. 1 and Table I ).
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Critical appraisal
Based on the QUIPS tool, the most commonly found risk factors for bias in the studies reviewed included participation, ASD measure used, and study confounds (see Table II ). Key issues with participation in studies were (1) using a non-representative sample, (2) high proportion or unspecified exclusion of eligible persons, or (3) not providing baseline sample descriptives. Key issues with ASD measures used involved (1) not adequately describing ASD measures or (2) using non-diagnostic or self-reported ASD measures. For study confounds, key issues were (1) not reporting intellectual disability or other confounds, (2) not providing definitions of intellectual disability measures, or (3) not accounting for intellectual disability or other confounds in study design and analysis. Trends of risk for bias did not seem to be related to the type of epilepsy, sample size, or age of sample, with relatively even levels of risk found in all study types. However, a general trend was found for studies with the highest number of risk factors for bias reporting higher epilepsy prevalence.
Pooled estimates
Reilly et al. 32 was removed from statistical analysis as the population and testing were the same as in Reilly et al. 31 An ASD pooled prevalence of 6.3% was found for overall epilepsy ( Fig. 2 and Table III) . Once divided by type of epilepsy, the risks of ASD for general epilepsy (i.e. all epilepsy types included), infantile spasms, complex partial seizures, and Dravet syndrome were 4.7%, 19.9%, 41.9%, and 47.4% respectively. Studies with mean population ages under 18 years had a 13.2 times greater risk of ASD than older samples. Studies with a majority (>50%) of participants with intellectual disability also showed a 4.9 times greater risk over studies with a minority (<50%) of participants with intellectual disability. Further, studies with the highest number of risk factors (3/4) had 2.6 times greater risk for ASD then studies with the lowest number of risk factors (1/4). The estimated 95% predictive interval for data was between 3.9 and 8.6.
Risk factors
In the studies reviewed, risk factors consistently reported (in at least four studies) included presence of intellectual What this paper adds
• Critical evaluation of previous studies examining the prevalence of autism spectrum disorder (ASD) in individuals with epilepsy.
• A meta-analysis of 19 studies showed a pooled ASD prevalence of 6.3% in individuals with epilepsy.
• Studies that included a majority of individuals with intellectual disability or younger population age had a higher prevalence of autism.
• Risk factors reported in studies included presence of intellectual disability, sex, age, and symptomatic epilepsy origin. disability, male sex, earlier age at epilepsy onset, and symptomatic origin of epilepsy. Other risk factors less frequently reported (in no more than three studies) included seizure recurrence, duration of epilepsy, neural abnormalities, and parental epilepsy. Risk factors inconsistently reported were type of epilepsy, seizure frequency, and number of antiepileptic drugs, with conflicting results found between studies (see Table IV ).
DISCUSSION
This review analysed all studies that examined the prevalence of ASD in a population with epilepsy over the past 15 years, which matched the current search criteria. A pooled prevalence of 6.3% for ASD was found in individuals with epilepsy, which is substantially higher than the reported prevalence of 0.75% to 1.1% in the general population. 4, 5 This rate is similar to two recent, large-scale, population-based studies examining epilepsy in ASD, which found a 6.3% and 6.6% likelihood of epilepsy in ASD. 50, 51 A higher prevalence was found for studies with younger age groups, higher rates of reported intellectual disability, and specific epilepsy syndromes (infantile spasms, complex partial seizures, Dravet syndrome).
Epidemiology
The wide variance in prevalences found in the current review probably arises from baseline and methodological differences between studies. Differences in baseline sample characteristics include epilepsy type, presence/definition of intellectual disability, age at testing, and sex ratio. As this study found sex, presence of intellectual disability, and epilepsy type to impact ASD comorbidity, variance in these factors may have a substantial impact on the different prevalences reported.
Methodological differences between studies, such as in study design, sample size and characteristics, inclusion/exclusion criteria, definitions of epilepsy and ASD, and method of ASD assessment, may also impact the prevalence statistics reported. For instance, where epilepsy was typically defined as the presence of two unprovoked seizures more than 24 hours apart, 34 one study only required one seizure; 49 and in studies that used self-reported surveys, exact epilepsy definition could be subjective according to each participant. Where ASD was typically diagnosed using a clinical assessment between ages 3 and 5, 52 at least four studies began testing as early as 1 year, a developmental stage where ASD symptoms may not yet be present or reliably tested. Another key methodological difference may have been the variability in testing measures used to diagnose ASD. Specifically, numerous studies used early screening questionnaires over formal diagnostic measures, which increase the risk of false positives for ASD in individuals with epilepsy. 53 For example, Eom et al. 33 reported a 54% risk of ASD using an early ASD screening measure; however, only 6% proceeded to receive a formal ASD diagnosis using later diagnostic measures. It is possible that early ASD screening measures are confounded by intellectual disability or developmental delay, which are common among individuals with epilepsy. 23 Thus, studies using early ASD questionnaires and screening measures may not assess ASD risk directly, but rather more general risks for a broader developmental delay or intellectual disability. Further, sample size may contribute to prevalence inconsistencies, with the two population-based nationwide studies reporting the lowest prevalences of 1.3% and 1.6%. 39, 41 However, in these studies, rates of ASD were still elevated relative to the general population (e.g. in Sundelin et al., comparison individuals showed an atypically low ASD rate of only 0.2%). 39 Further, Sundelin et al. 39 reported a hazard ratio of 10.5 (95% confidence interval [CI] 9.6-11.5) and Selassie et al. 41 reported an odds ratio of 22. Review 21 to smaller studies, but still reported high prevalence risk relative to the general population. When studies were assessed for methodological risk factors for bias in the current critical appraisal, the highest number of risks for bias (3/4) found a 2.6 times increase in pooled prevalence than studies with the lowest number of risks for bias (1/4). This demonstrates that certain methodological considerations, including sample characteristics, ASD definition/measurement, and/or consideration of intellectual disability and other confounds, may augment prevalence scores reported.
Clinical characteristics Intellectual disability
Intellectual disability is defined by an IQ score less than or equal to 70, accompanied by impairments in conceptual, social, and practical adaptive functioning. 3 This review found that when the majority of a study's sample had an intellectual disability, there was more than a sevenfold risk of developing ASD than samples with a minority with intellectual disability. This finding is similar to previous studies of epilepsy in the ASD population, where intelligence levels were found to be inversely correlated with the risk of epilepsy.
14 Interestingly, the pooled prevalences for ASD in individuals with and without intellectual disability in the epilepsy population (38.9% vs 5.2%) were higher than those reported for epilepsy with and without intellectual disability in the ASD population (23.7% vs 1.8%). 17 Overall, these results support the strong connection between intellectual disability, epilepsy, and ASD. 54 
Sex
The majority of studies that examined sex differences in people with ASD found an increased risk in males, which is consistent with higher male prevalence for ASD in the general population. 55 However, the male:female sex ratios for ASD in these studies were between 1.58:1 (Clarke et al.) 38 and 2.4:1 (Matsuo et al.), 37 which are substantially below the general population ASD sex ratio of 4:1. 55 Therefore, the risk may actually be higher in females when base rate sex differences for ASD in the general population are considered. This is consistent with Sundelin et al. 39 and Su et al., 30 who reported a higher number of males developing epilepsy, but a higher hazard ratio for females once ASD base rates in comparison samples were considered. This is also consistent with previous studies in ASD populations, which reported higher epilepsy risk in females. 7, 50 One potential reason for this may be that a higher proportion of females with ASD have severe intellectual disability than males, which predisposes them to epilepsy risk. 55 
Age
Samples with a mean age under 18 years had a 13.2 times higher risk of ASD relative to samples over 18 years. The earlier a sample is tested, the younger the individuals may have onset of epilepsy, and earlier seizure onset is a known risk factor for poorer neurodevelopmental outcomes. 56, 57 Clarke et al. 38 found that the greatest risk for developing ASD was in patients with seizure onset before 2 years. One further study found that 80% of children with both ASD and epilepsy had their seizure onset in the first year of life. 58 This may be caused by the contributing role of disruptive seizures in ASD during early development. These findings support the theory that early seizure activity may play a role in the atypical development seen in ASD.
Seizure type
In ASD research, there is no predominant epilepsy type or syndrome reported. 59 However, some of the larger studies have found focal seizures with a dyscognitive component Table II ). ASD, autism spectrum disorder; CI, confidence interval; df, degrees of freedom; IS, infantile spasms; ID, intellectual disability. Inclusion of intellectual disability: studies that report under/over 50%.
Review 25 Russ et al. 36 Matsuo et al. Rai et al. 40 Selassie et al. 41 Matsuo et al. (i.e. complex partial seizures) more commonly reported than primary generalized seizures. 50 In the current review, numerous studies found focal epilepsy reported in a majority of individuals who developed ASD. 32, 33, 37 Although only one study examined focal seizures explicitly, it found an 8.9 times greater risk of ASD development relative to generalized epilepsy. One potential reason for this is that focal seizures are the most common seizure type seen in individuals with epilepsy onset at 10 years or younger, whereas generalized convulsive seizures are seen in most individuals with later onset. 37 This suggests that focal seizures may be a risk for ASD-epilepsy comorbidity, with age at epilepsy onset serving as a potential mediator.
Contrary to findings in ASD research, the current review did find that different epilepsy syndromes (i.e. infantile spasms and Dravet syndrome) demonstrated increased ASD risk relative to general epilepsy. One reason for this is that both Dravet syndrome and infantile spasms tend to onset within the first year of life, which has been previously mentioned as an increased risk factor for ASD. 48, 60 Dravet syndrome, which showed the highest risk, is a genetic form of epilepsy with mutations in the SCN1A gene. 61 Findings on Dravet syndrome may demonstrate that underlying genetic aetiologies lead to more severe risk for intellectual disability and ASD, as further discussed below.
Underlying aetiology
Previous studies in the ASD population have found that syndromic ASD (i.e. associated with underlying neural/genetic abnormalities) had a higher epilepsy risk than idiopathic ASD (i.e. no known cause). 59 For instance, Pavone et al. 62 found that epilepsy was seen in 55% of patients with syndromic ASD, compared with only 7.4% of individuals with idiopathic ASD. Similarly, most studies reviewed demonstrated that individuals with secondary epilepsy (i.e. cause by underlying neural/genetic condition) had a higher risk for ASD than individuals with idiopathic epilepsy (i.e. no known cause). These findings are aligned with theories that one abnormal neural dysfunction may make the brain more susceptible to other neurological disorders. 21 This supports the hypothesis that epilepsy, intellectual disability, and ASD may all be the result of a mutual underlying neurological condition. Further research is needed to understand which underlying biological mechanisms or abnormalities can simultaneously raise risk for these disorders and how these processes occur.
Family history
Family history of ASD has been consistently reported as a risk factor for ASD development in the general population, 63 but was not reported in any study as a risk factor in the current review. This implies that the underlying cause or development of ASD in the epilepsy population may differ from that in the general population, potentially because of the presence of detrimental seizures or underlying genetic or neural abnormalities. Further, some studies have found that a family history of ASD or epilepsy has been linked to a greater risk for the other disorder. 64 In a study of ASD, multiplex families (i.e. more than one family member with ASD) had a 12.8% epilepsy prevalence relative to 2.4% seen in simplex families (i.e. only one family member with ASD). 8 In addition, unaffected siblings from multiplex families had a 2.3% epilepsy prevalence, a rate nearly double that in the general population. 64 Similarly, Sundelin et al. 39 found that siblings and offspring of individuals with epilepsy were also at substantially elevated risk for ASD. This supports the theory that there may be a common underlying genetic cause, and brings forth an interesting question of whether there is some heritable underpinning that predisposes individuals to either condition, and accounts for the high comorbidity seen between conditions. Further research is needed to explore this idea to provide novel insight into the inheritance patterns, and potential overlap, of these disorders.
Directionality
Only a few of the studies reviewed explicitly addressed the matter of directionality. Matsuo et al. 35 and Berg et al. 37 found epilepsy to precede ASD in 36.7% (vs 25.3% with ASD first) and 85.7% (vs 14.3% with ASD first) of cases respectively. In both these studies, epilepsy diagnosis more often preceded ASD diagnosis than vice versa. Matsuo et al. 37 compared the populations and found less impaired intellectual disability, younger age at epilepsy onset, and older age at ASD diagnosis in individuals initially diagnosed with epilepsy over those initially diagnosed with ASD. This implies that the presentation of the epilepsy-ASD comorbidity may be different, depending on which condition develops first. A recent nationwide study by Su et al. 30 found that epilepsy was present in 13.7% of individuals with primary ASD (i.e. diagnosed with ASD before epilepsy) and ASD was present in 3.4% of individuals with primary epilepsy (i.e. diagnosed with epilepsy before ASD). This implies that different cooccurrence rates occur, depending on which diagnosis presents first. However, it is important to note that ASD symptoms may be present in these populations before they can be formally diagnosed at around 3 to 5 years of age, 52 or epilepsy may have been present earlier but have gone unrecognized. Therefore, exact directionality is difficult to determine based on presenting symptoms and formal diagnosis. This study does, however, demonstrate that the presence of either condition significantly increases risk for the other disorder, an effect that was augmented by the presence of intellectual disability. Further research is required explicitly addressing the directionality of this relationship to determine the possible role of epilepsy in the development of ASD, or vice versa.
Limitations
One main limitation in the current review was that the vast heterogeneity in the sample size, population characteristics, and methodology of all the studies made these samples difficult to compare. For example, individual studies varied in their definitions of ASD and epilepsy, classification of seizure types and epilepsy syndromes, and the reliability of ASD assessment tools used. Further, this review found risk factors for bias varied greatly between studies, thus implying that each study may have varied in how it represented the population as a whole. Overall, it is suggested that future research use standardized definitions and classifications of disorders and validated ASD diagnostic tools to provide more reliable information which can be easily compared across studies.
Clinical implications
By providing information on the prevalence and risk factors for ASD in epilepsy, this review intended to better define the clinical characteristics of a patient who is at risk for ASD development. These steps are necessary to allow clinicians to predict future cooccurrence and possibly lead to earlier screening and diagnosis, which is a fundamental step in producing positive developmental outcomes in ASD. 65 Further, presence of intellectual disability and ASD in this population may help to decide the level of care and support provided to individuals and families. Previous research has found that children with epilepsy and comorbid intellectual disability have more than double the average number of care needs relative to children with epilepsy without intellectual disability. These children with epilepsy and intellectual disability have an increased presence of medical conditions (e.g. acquired brain injury, visual impairments, congenital brain, heart and other anomalies, constipation, disordered sleep, microcephaly, gastro-oesophageal reflux, recurrent chest infection) and language, behavioural, and emotional disorders, as well as increased rates of family, school, housing, and child protection issues, relative to those without intellectual disability. 66 Thus, health care professionals working with individuals with epilepsy must be well trained and capable of identifying intellectual disability and ASD in this population, in order to provide early intervention and appropriate care.
A better understanding of the presentation and underlying factors of comorbid epilepsy-ASD may also help clinicians and families to develop targeted therapies for individuals with these comorbid conditions. At present, the specific role of epilepsy in ASD is unclear; however, owing to the high comorbidity between these disorders, the potential contributing role of epilepsy should not be overlooked. Numerous studies have indeed reported regression in ASD to be associated with an increase in epileptic activity. 67, 68 Thus, care and interventions in this population need to actively integrate identification and treatment of epilepsy and ASD, and monitor potential bidirectional impacts.
CONCLUSION
This review found an overall pooled prevalence of 6.3% for ASD in epilepsy. Higher prevalence was found in studies with younger age, greater inclusion of intellectual disability, and specific epilepsy syndromes (infantile spasms and Dravet syndrome). The reviewed studies also highlighted sex, symptomatic epilepsy, age at epilepsy onset, and underlying brain abnormalities as risk factors for ASD development. This information may be used to form a clinical profile of a patient with epilepsy who is at risk for ASD, which may allow for earlier diagnosis and intervention. Much further research is needed to define the relationship and directionality between epilepsy and ASD to determine whether underlying commonalities, causative impacts of seizures, or both factors contribute to the increased prevalence of ASD seen in individuals with epilepsy.
